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hould We Abandon
omografts?*
ohn A. Elefteriades, MD
ew Haven, Connecticut
he paper by El-Hamamsy et al. (1) in this issue of the
ournal originates from the group of the distinguished Sir
agdhi Yacoub, who has unsurpassed experience in the
reatment of the diseased aortic root. This study appropri-
tely identifies a question whose answer is unknown: spe-
ifically, whether an animal aortic root (Medtronic Freestyle
raft, porcine in origin [Medtronic Inc., Minneapolis,
innesota]) or a homograft is a better option when a
iological root replacement is required.
This study by El-Hamamsy et al. (1) is valuable for a
ariety of reasons: not only is the main study question
ppropriate, but also the study is randomized (within a
ingle center) and of long duration (median follow-up 7.6
ears). Also, the Freestyle and homograft groups are re-
arkably similar in their baseline characteristics, setting an
ppropriate stage for outcome comparison.
The study was commercially funded (Medtronic makes
he Freestyle graft), although none of the investigators
dentified personal financial conflicts of interest.
See page 368
The study showed excellent overall results, with a 1%
urgical mortality among patients undergoing only root
eplacement (without concomitant procedures) and 4.8%
verall; the mortality is increased by the need for concom-
tant procedures (mainly coronary artery bypass graft
urgery).
The main findings of the study include the following:
) there was no difference in hospital mortality between
reestyle and homograft groups; 2) there was no difference
n late valve-related complications; 3) there was no differ-
nce in late functional class; 4) there was no difference in
ate survival (which, in both groups, approached that of an
ge- and sex-matched general population); and 5) there was
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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eceived research support from Celera and NSF, and has principal in CoolSpine.
edtronic manufactures the graft reported in the paper to which this editorial applies.marked difference in valve performance, with the ho-
ografts showing a much higher incidence of aortic valve
ysfunction (86% vs. 37%, p  0.001) and need for
eoperation, which occurred only in the homograft group
all for valve dysfunction).
The longer follow-up is an important strength of this
tudy. All too often in reports of biological valves, follow-up
s inadequate to reveal valve deficiencies and deterioration,
hich are usually late phenomena. Indeed, a prior, short-
erm report of the same patients from the Yacoub group
evealed no significant differences, even in valve function. In
he present paper by El-Hamamsy et al. (1), thanks to the
onger-term follow-up, valve deficiencies do come to light.
hese deficiencies are all confined to the homograft group,
ith the Freestyle valves showing consistently excellent
erformance in the longer follow-up.
Shortcomings of the study include the following. 1) The
n” was not great (166 total between the 2 groups). 2) The
ollow-up still falls within the range best described as
midterm,” with the longest patients only 11 years out from
urgery, and as we know vividly from studies of biological
alves of all types, 20-year follow-up is really necessary to
now a valve’s true colors. 3) Follow-up was not entirely
omplete (87% and 88% in the 2 groups). In this electronic
ra, we hope that computerized national registries of citi-
ens can provide close to 100% follow-up, at least as regards
patient’s being alive or dead. One always fears that lost
atients may be dead patients or dissatisfied patients who
ave turned elsewhere for their subsequent care. 4) There
re some potential sources of bias that may favor the
reestyle group. First, there is an exclusion criterion for “a
nown systemic illness affecting long-term survival”; this is
broad criterion, and subconscious investigator bias can
ccasionally operate via such exclusion criteria. Second, late
chocardiographic follow-up was a bit more complete in the
omograft group (83% vs. 76%), raising the possibility that
here was better detection of valve problems in the ho-
ograft patients. 5) Not all homografts are the same. In
act, 2 different kinds were used in this study, 1 “fresh” and
ntibiotic sterilized and the other cryopreserved. A variety of
echniques and manufacturers provide disparate types of
uman aortic roots, which fall under the heading of “ho-
ograft.” The long-term behavior of these different sub-
ypes may vary. 6) There are 2 curious negative findings
ffecting the Freestyle group. Eight patients in the Freestyle
roup required renal replacement therapy compared to 1 in
he homograft group; the reason for this difference between
he 2 groups is unclear. Similarly, 8 patients in the Freestyle
roup (as opposed to none in the homograft group) had
eart block. 7) For 7 patients in the Freestyle group, the
ause of death was unknown, compared with only 2 un-
nown causes of death in the homograft group; this finding
aises the possibility of an undetected cardiac problem in
hose Freestyle patients. When all is said and done, all these
oncerns represent relatively minor shortcomings for a study
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Should We Abandon Homografts? January 26, 2010:377–8onducted in a “real-world” setting, and the findings of this
tudy deserve notice and accommodation in our practices
nd policies.
Specifically, this study provides relatively strong evidence
n favor of our using animal aortic roots over homografts.
he late valve deterioration in the homograft roots pin-
ointed in this study deserves notice and respect from the
ardiologic and cardiac surgical communities.
The curious susceptibility of homograft aortic roots to
alcify has not been fully explained, but appears to be an
mmune reaction to cells remaining in the homograft (2–4).
his propensity to structural deterioration in the homograft
ortic wall is likely related to the tendency for the valve itself
o deteriorate.
It is important to look at the general context of this paper,
n addition to the specifics. One should consider the general
hoice of valve or root replacement prosthetics. El-
amamsy et al. (1) point out, and illustrate in their last
gure, the mechanical inferiority of stented biological
alves, in terms of effective functional valve area, and they
mphasize the long-term downstream benefits of maximiz-
ng prosthetic aortic valve functional cross-sectional area.
owever, most surgeons would perform a valve replacement
ather than a full root replacement for isolated aortic
tenosis, which was the primary problem in most of the
atients in the present paper.
Another option for root replacement is, of course, a
echanical composite graft. Our own data (5), among those
f others, indicate that a mechanical valved conduit is an
lmost “bullet proof” choice for the contingent with aortic
alve disease and root aneurysm, yielding almost undetect-
ble bleeding and embolism rates yet conferring the excel-
ent hemodynamics and durability of a mechanical valve. It
s worth noting that, in the present study, despite having a
iological valve, nearly one-quarter of both the Freestyle
nd homograft patients were receiving warfarin therapy.
K
dThe present study cannot clarify or resolve the strong
ebates and prejudices regarding choice of stented versus
onstented or biological versus mechanical valves. This
mportant study by El-Hamamsy et al. (1) does, however,
how us that when we do wish to implant an unstented
iological valve, we should choose a Freestyle graft over a
omograft. Such a choice will optimize the likelihood of
urable valve function in the medium term.
As the authors point out, endocarditis does provide the 1
xception that favors the use of a homograft, because of the
unique benefit due to the mitral flange,” which can be of
mmense technical utility in filling voids and infected spaces
n an aortic root decimated by infection.
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